Online Database of Chemicals from Around the World

Ciprofloxacin lactate
[CAS# 97867-33-9]

List of Suppliers
Simagchem Corporation China Inquire
www.simagchem.com
+86 13806087780
+86 (592) 268-0237
sale@simagchem.com
Chemical manufacturer since 2002
chemBlink Standard supplier since 2008
Microsin SRL Romania Inquire
www.microsin.ro
+40 (21) 345-2066
+40 (21) 345-2067
office@microsin.ro
Chemical manufacturer since 1991
chemBlink Standard supplier since 2008
Arshine Technology Co., Ltd. China Inquire
www.arshine.com.cn
+86 (755) 3333-0822
+86 (755) 8287-9323
marketing@arshine.com.cn
Chemical manufacturer
chemBlink Standard supplier since 2010
Hefei TNJ Chemical Industry Co., Ltd. China Inquire
www.tnjchem.com
+86 (551) 6541-8684
+86 (551) 6541-8697
sales@tnjchem.com
Chemical manufacturer since 2001
chemBlink Standard supplier since 2010
Ningbo Hi-Tech Biochemicals Co., Ltd. China Inquire
www.hi-techbiochem.com
+86 (574) 2786-5813
+86 (574) 2771-1846
info@hi-techbiochem.com
peng.shifeng@hi-techbiochem.com
Chemical manufacturer since 2006
chemBlink Standard supplier since 2010
BOC Sciences USA Inquire
www.bocsci.com
+1 (631) 485-4226
+1 (631) 614-7828
info@bocsci.com
Chemical manufacturer
chemBlink Standard supplier since 2010
Medilink Pharmachem India Inquire
www.medilinkpharma.com
+91 (79) 3007-0133
+91 (79) 4007-4175
exports@medilinkpharma.com
Chemical distributor since 1996
chemBlink Standard supplier since 2014
Hangzhou Leap Chem Co., Ltd. China Inquire
www.leapchem.com
+86 (571) 8771-1850
market19@leapchem.com
QQ Chat
Chemical manufacturer since 2006
chemBlink Standard supplier since 2015
Turtle Pharma Private Limited India Inquire
www.turtlepharma.com
+91 9850998504
info@turtlepharma.com
Chemical manufacturer since 2015
chemBlink Standard supplier since 2024

Identification
ClassificationAPI >> Synthetic anti-infective drugs >> Quinolone
NameCiprofloxacin lactate
Synonyms1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid lactate
Molecular StructureCAS # 97867-33-9, Ciprofloxacin lactate
Molecular FormulaC17H18FN3O3.C3H6O3
Molecular Weight421.43
CAS Registry Number97867-33-9
EC Number809-928-8
SMILESCC(C(=O)O)O.C1CC1N2C=C(C(=O)C3=CC(=C(C=C32)N4CCNCC4)F)C(=O)O
Properties
Melting point255-257 °C
Safety Data
Hazard Symbolssymbol   GHS07 Warning  Details
Risk StatementsH312-H315-H319-H335  Details
Safety StatementsP261-P305+P351+P338  Details
SDSAvailable
up Discovery and Applications
Ciprofloxacin lactate is a derivative of ciprofloxacin, a well-known fluoroquinolone antibiotic. It is utilized primarily in the treatment of bacterial infections, offering a unique formulation of its parent compound. This article explores the discovery, development, and applications of ciprofloxacin lactate, highlighting its significance in both medical and pharmaceutical contexts.

The discovery of ciprofloxacin dates back to the 1980s when it was developed by Bayer AG as part of a broader effort to enhance the fluoroquinolone class of antibiotics. Ciprofloxacin itself is renowned for its broad-spectrum antibacterial activity, targeting a wide range of Gram-negative and Gram-positive bacteria. Its efficacy in treating complex infections has established it as a cornerstone in antibiotic therapy. Ciprofloxacin lactate, introduced subsequently, was designed to offer specific advantages in formulation and application.

Ciprofloxacin lactate is the lactate salt form of ciprofloxacin, which improves its solubility and stability compared to the base form. This formulation is particularly useful for intravenous administration, allowing for rapid delivery and absorption of the antibiotic in clinical settings. By converting ciprofloxacin into its lactate salt, pharmaceutical scientists were able to optimize its pharmacokinetic properties, making it suitable for more critical and immediate medical needs.

The primary application of ciprofloxacin lactate is in treating severe infections where oral administration of ciprofloxacin may not be feasible. It is commonly used in hospitals for managing complex infections, including those affecting the respiratory tract, urinary tract, and gastrointestinal system. Ciprofloxacin lactate is particularly effective against infections caused by Pseudomonas aeruginosa and other challenging pathogens. Its ability to achieve high plasma concentrations quickly makes it a valuable option for treating life-threatening infections where prompt intervention is crucial.

In clinical practice, ciprofloxacin lactate is administered intravenously, which allows for precise control over dosing and ensures that the drug reaches therapeutic levels swiftly. This method of delivery is essential in acute care settings where rapid antibiotic action is needed to combat severe bacterial infections. The lactate form enhances the drug’s solubility, facilitating its use in injectable formulations that are stable and effective.

Despite its benefits, the use of ciprofloxacin lactate, like other antibiotics, requires careful consideration of potential side effects and resistance issues. Common side effects include gastrointestinal disturbances, headache, and rash. Additionally, overuse or inappropriate use of ciprofloxacin lactate can contribute to the development of antibiotic-resistant bacteria. Therefore, it is essential for healthcare providers to follow guidelines for appropriate use and to monitor patients closely during treatment.

The development of ciprofloxacin lactate represents an important advancement in antibiotic therapy, expanding the options available for treating severe bacterial infections. Its formulation enhances the efficacy of ciprofloxacin, making it a valuable tool in the management of critical infections. As with all antibiotics, its use must be managed carefully to preserve its effectiveness and minimize the risk of resistance.

In summary, ciprofloxacin lactate is a crucial derivative of ciprofloxacin, offering improved solubility and stability for intravenous administration. Its role in treating severe bacterial infections underscores its importance in modern medical practice, particularly in settings requiring rapid and effective antibiotic treatment.

References

2019. Photodynamic enhancement of the activity of antibiotics used in urinary tract infections. Lasers in Medical Science, 34(8).
DOI: 10.1007/s10103-019-02730-7

2009. Determination of ciprofloxacin hydrochloride in pharmaceutical preparation and biological fluid by Rayleigh light scattering technique. Wuhan University Journal of Natural Sciences, 14(1).
DOI: 10.1007/s11859-009-0115-y

2009. The complexes of metal ions with fluoroquinolones. Russian Journal of Coordination Chemistry, 35(2).
DOI: 10.1134/s1070328409020018
Market Analysis Reports
List of Reports Available for Ciprofloxacin lactate
Related Products
Ciprofloxacin  Ciprofloxacin E...  Ciprofloxacin E...  Ciprofloxacin E...  Ciprofloxacin E...  Ciprofloxacin E...  Ciprofloxacin g...  Ciprofloxacin h...  Ciprofloxacin h...  Ciprofloxacin h...  Ciprofloxacin N...  Cipropride  Ciproquazone  Ciproquinate  Ciprostene  Ciprostene calc...  Ciproxidine  Ciproximide  Ciramadol  Ciramadol